Skip to main content

Go to the home page

About
News
Investors
Careers
Contact

Request Information

Go to the home page

About
News
Investors
Careers
Request Information

Contact
Robotics Today

Vicarious Surgical completes Beta 2 system design

08.09.22 / MassDevice

Vicarious Surgical robot

Vicarious Surgical (NYSE:RBOT) continues to progress in the development of its Beta 2 robotic surgery platform.

Read Entire Article on MassDevice

Share on Twitter
Share on Facebook
Share on LinkedIn
Email this

Resources

Investors
Robotics Today

About

Company
Careers
Contact
Request Information

The Vicarious Surgical System is being designed with the intent to improve surgery. All information in this website represents the design goals of Vicarious Surgical and has not been evaluated by the FDA, aside from evaluations for the purpose of granting a Breakthrough Device Designation. The product has not been cleared by the FDA and is not for commercial sale in the United States.

© 2026 - Vicarious Surgical. All Rights Reserved.

Intellectual Property Notice

Disclaimer

The Vicarious Surgical System is being designed with the intent to improve surgery. All information in this website represents the design goals of Vicarious Surgical and has not been evaluated by the FDA, aside from evaluations for the purpose of granting a Breakthrough Device Designation. The product has not been cleared by the FDA and is not for commercial sale in the United States.